N-terminal heterogenicity of amyloid protein examined in Alzheimer's disease

Int J Neurosci. 2004 Jan;114(1):75-81. doi: 10.1080/00207450490249455.

Abstract

Alzheimer's disease is the major cause of dementia in humans. The affected brain shows characteristic abnormal filamentous proteins that accumulate intracellularly as neurofibrillary tangles, and extracellularly as senile plaques, as well as in cerebral blood vessels. The extracellular deposits are an amyloid protein, which is highly insoluble. In our study, we intended to show that the N-terminus of amyloid A4 protein can change in length and sequence in Alzheimer's disease, and possibly in other dementias.

Publication types

  • Comparative Study

MeSH terms

  • Alzheimer Disease / metabolism*
  • Alzheimer Disease / pathology
  • Amino Acid Sequence
  • Amyloid beta-Peptides / chemistry*
  • Amyloid beta-Peptides / metabolism
  • Brain Chemistry
  • Chromatography, High Pressure Liquid
  • Humans
  • Plaque, Amyloid / metabolism
  • Sequence Analysis, Protein

Substances

  • Amyloid beta-Peptides